Alnylam Pharmaceuticals, Inc. (ALNY)
Company Info
| ISIN | US02043Q1076 |
|---|---|
| CUSIP | 02043Q107 |
| Sector | Healthcare |
| Industry | Biotechnology |
Trading Data
| Previous Close | $226.40 |
|---|---|
| Year Range | $120.42 - $241.31 |
| EMA (50) | $225.55 |
| EMA (200) | $194.32 |
| Average Volume | $743.07K |
| Market Capitalization | $27.73B |
ALNYShare Price Chart
Loading data...
ALNYPerformance
The chart shows the growth of $10,000 invested in Alnylam Pharmaceuticals, Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $124,807 for a total return of roughly 1,148.07%. All prices are adjusted for splits and dividends.
ALNYCompare to other instruments
ALNYReturns in periods
| Period | Return | Benchmark |
|---|---|---|
| 1M | -4.73% | 6.18% |
| YTD | -4.73% | 6.18% |
| 6M | 61.77% | -1.02% |
| 1Y | 71.40% | -8.02% |
| 5Y | 11.76% | 7.63% |
| 10Y | 25.08% | 10.44% |
ALNYMonthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -2.61% | 45.50% | -3.15% | 3.55% | 6.43% | 7.73% |
ALNYDividend History
Alnylam Pharmaceuticals, Inc. doesn't pay dividends
ALNYDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
ALNYWorst Drawdowns
The table below shows the maximum drawdowns of the Alnylam Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Alnylam Pharmaceuticals, Inc. is 77.36%, recorded on Nov 3, 2016. It took 257 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -77.36% | Jun 23, 2015 | 347 | Nov 3, 2016 | 257 | Nov 10, 2017 | 604 |
| -67.95% | Jan 12, 2010 | 436 | Oct 3, 2011 | 197 | Jul 16, 2012 | 633 |
| -57.81% | Mar 21, 2018 | 193 | Dec 24, 2018 | 374 | Jun 19, 2020 | 567 |
| -47.61% | Jan 14, 2014 | 72 | Apr 28, 2014 | 126 | Oct 24, 2014 | 198 |
| -42.46% | Oct 15, 2021 | 144 | May 11, 2022 | 57 | Aug 3, 2022 | 201 |
| -27.49% | Sep 18, 2012 | 36 | Nov 8, 2012 | 46 | Jan 16, 2013 | 82 |
| -26.79% | Jan 26, 2021 | 73 | May 10, 2021 | 28 | Jun 18, 2021 | 101 |
| -26.77% | Jul 21, 2020 | 37 | Sep 10, 2020 | 85 | Jan 12, 2021 | 122 |
| -23.21% | Oct 3, 2013 | 31 | Nov 14, 2013 | 25 | Dec 20, 2013 | 56 |
| -20.84% | Aug 15, 2022 | 42 | Oct 12, 2022 | 36 | Dec 2, 2022 | 78 |
ALNYVolatility Chart
Current Alnylam Pharmaceuticals, Inc. volatility is 18.93%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.